Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AKERO THERAPEUTICS, INC.

(AKRO)
  Report
Delayed Nasdaq  -  04:00:00 2023-03-21 pm EDT
37.27 USD   -2.20%
03/20Canaccord Genuity Adjusts Akero Therapeutics Price Target to $58 From $50, Maintains Buy Rating
MT
03/17Akero Therapeutics Signs Open Market Sale Agreement; May Sell $200 Million Common Shares From Time-to-Time
MT
03/17Akero Therapeutics, Inc. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart AKERO THERAPEUTICS, INC.
Upcoming events on AKERO THERAPEUTICS, INC.
05/17/23 Q1 2023 Earnings Release (Projected)
11/15/23 Q3 2023 Earnings Release (Projected)
03/14/24 FY 2023 Earnings Release (Projected)
05/15/24 Q1 2024 Earnings Release (Projected)
Past events on AKERO THERAPEUTICS, INC.
03/17/23 | 07:00am FY 2022 Earnings Release
01/10/23 | 02:30pm JP Morgan Healthcare Conference
11/29/22 | 01:10pm Evercore ISI HealthCONx Conference
11/17/22 | 04:00am Jefferies London Healthcare Conference
11/07/22 | 03:00pm American Association for the Study of Liver Diseases Meeting - Abstract No. 5006
11/07/22 | 02:00pm American Association for the Study of Liver Diseases Meeting - Abstract No. 5051
11/04/22 | 07:00am Q3 2022 Earnings Release
10/17/22 | 01:00pm Wainwright Nash Virtual Investor Conference
09/13/22 | 09:00am HARMONY Phase 2b Trial Results Call
06/16/22 | 08:00pm Tissue Fibrosis and Repair Mechanisms, Human Disease and Therapies Symposium - Tim Rolph
Past dividends on AKERO THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December20192020202120222023
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-45,7
-44,7
-2,1%
-74,1
-67,6
-9,6%
-101
-97,0
-4,0%
-115
-123
6,4%
 
-141
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-45,7
-45,0
-1,3%
-80,2
-70,2
-14%
-101
-96,9
-4,1%
-115
-125
8,1%
 
-139
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-43,8
-45,1
3,0%
-79,2
-69,2
-14%
-101
-96,8
-4,1%
-112
-125
10%
 
-144
 
Net income
M $
Released
Forecast
Spread
-43,8
-45,6
4,1%
-79,2
-68,6
-15%
-101
-96,5
-4,5%
-112
-125
10%
 
-138
 
EPS
$
Released
Forecast
Spread
-2,90
-2,83
-2,4%
-2,52
-2,20
-14%
-2,89
-2,76
-4,9%
-2,87
-3,22
11%
 
-2,90
 
Announcement Date03/16/202003/16/202102/25/202203/17/2023-
Quarterly results
Fiscal Period : December2021 Q42022 Q12022 Q22022 Q32022 Q42023 Q1
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-32,4
-28,0
-16%
-26,0
-29,0
10%
-27,6

 
-36,1
-32,0
-13%
-25,4
-37,0
31%
 
-28,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-32,4
-28,1
-15%
-26,1
-28,2
7,8%
-27,6
-33,8
18%
-36,1
-30,4
-19%
-25,4
-35,9
29%
 
-30,5
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-32,4
-28,5
-14%
-26,0
-29,3
11%
-27,4
-33,8
19%
-35,5
-30,8
-15%
-23,1
-36,0
36%
 
-31,0
 
Net income
M $
Released
Forecast
Spread
-32,4
-28,1
-15%
-26,0
-28,2
7,8%
-27,4
-33,8
19%
-35,5
-30,3
-17%
-23,1
-35,6
35%
 
-30,3
 
EPS
$
Released
Forecast
Spread
-0,93
-0,80
-16%
-0,74
-0,81
8,5%
-0,77
-0,90
15%
-0,92
-0,72
-28%
-0,49
-0,80
38%
 
-0,70
 
Announcement Date02/25/202205/06/202208/05/202211/04/202203/17/2023-
Previous year Next Year
Upcoming sector events for AKERO THERAPEUTICS, INC.
More events
Past sector events for AKERO THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise